首页> 外文期刊>PLOS Neglected Tropical Diseases >Utilization of proliferable extracellular amastigotes for transient gene expression, drug sensitivity assay, and CRISPR/Cas9-mediated gene knockout in Trypanosoma cruzi
【24h】

Utilization of proliferable extracellular amastigotes for transient gene expression, drug sensitivity assay, and CRISPR/Cas9-mediated gene knockout in Trypanosoma cruzi

机译:利用可增殖的胞外amastigotes用于瞬时基因表达,药物敏感性测定和CRISPR / Cas9介导的克鲁氏锥虫基因敲除

获取原文
           

摘要

Author summary We developed an experimental system to study amastigote stage of Trypanosoma cruzi as a proliferable axenic culture. Use of axenic amastigotes allows us to directly introduce exogenous gene into T. cruzi amastigote and select for drug resistant parasite to enrich the transfectants. Our strategy bypasses differentiation steps involved in conventional epimastigote transfection procedure to obtain transgenic amastigotes. Gene knockout can also be performed in amastigote-specific manner, using Cas9-expressing extracellular amastigotes. Drug sensitivity could also be assessed during 1-week axenic growth period. Our method potentially leads to variety of new experimental strategies to make amastigote-stage-specific manipulations and analyses possible.
机译:作者摘要我们开发了一个实验系统,以研究克氏锥虫作为可增殖的无性培养物的鞭毛阶段。使用抗微生物的变形虫可以使我们直接将外源基因引入克鲁氏锥虫,并选择具有抗药性的寄生虫来丰富转染子。我们的策略绕过了传统的近鞭毛体转染程序所涉及的分化步骤,以获得转基因变形虫。基因敲除还可以使用表达Cas9的胞外无鞭毛体以特定的鞭毛体方式进行。还可以在1周的焦虑症生长期间评估药物敏感性。我们的方法潜在地导致了各种新的实验策略,以使假肢阶段特定的操作和分析成为可能。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号